Literature DB >> 28104405

Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.

Andreia Almeida1, Bruno Sarmento2, Francisca Rodrigues3.   

Abstract

According to the current European legislation, the safety assessment of each individual cosmetic ingredient of any formulation is the basis for the safety evaluation of a cosmetic product. Also, animal testing in the European Union is prohibited for cosmetic ingredients and products since 2004 and 2009, respectively. Additionally, the commercialization of any cosmetic products containing ingredients tested on animal models was forbidden in 2009. In consequence of these boundaries, the European Centre for the Validation of Alternative Methods (ECVAM) proposes a list of validated cell-based in vitro models for predicting the safety and toxicity of cosmetic ingredients. These models have been demonstrated as valuable and effective tools to overcome the limitations of animal in vivo studies. Although the use of in vitro cell-based models for the evaluation of absorption and permeability of cosmetic ingredients is widespread, a detailed study on the properties of these platforms and the in vitro-in vivo correlation compared with human data are required. Moreover, additional efforts must be taken to develop in vitro models to predict carcinogenicity, repeat dose toxicity and reproductive toxicity, for which no alternative in vitro methods are currently available. This review paper summarizes and characterizes the most relevant in vitro models validated by ECVAM employed to predict the safety and toxicology of cosmetic ingredients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal alternatives; Cosmetics ingredients; In vitro models; Safety evaluation; Toxicity

Mesh:

Substances:

Year:  2017        PMID: 28104405     DOI: 10.1016/j.ijpharm.2017.01.024

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Tri-culture system for pro-hapten sensitizer identification and potency classification.

Authors:  Serom Lee; Talia Greenstein; Lingting Shi; Tim Maguire; Rene Schloss; Martin Yarmush
Journal:  Technology (Singap World Sci)       Date:  2018-06-29

2.  Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety.

Authors:  Fátima Pinto; Luis P Fonseca; Dragana P C de Barros
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  -Omics potential of in vitro skin models for radiation exposure.

Authors:  Leyla A Akh; Mohammad O Ishak; Jennifer F Harris; Trevor G Glaros; Zachary J Sasiene; Phillip M Mach; Laura M Lilley; Ethan M McBride
Journal:  Cell Mol Life Sci       Date:  2022-07-01       Impact factor: 9.207

4.  Simple and robust 3D bioprinting of full-thickness human skin tissue.

Authors:  Jing Liu; Zhengtong Zhou; Min Zhang; Feng Song; Chong Feng; Haochen Liu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  Modulation of the Lipid Profile of Reconstructed Skin Substitutes after Essential Fatty Acid Supplementation Affects Testosterone Permeability.

Authors:  Mélissa Simard; Pierre Julien; Julie Fradette; Roxane Pouliot
Journal:  Cells       Date:  2019-09-25       Impact factor: 6.600

Review 6.  Synthetic and Bio-Derived Surfactants Versus Microbial Biosurfactants in the Cosmetic Industry: An Overview.

Authors:  Ana B Moldes; Lorena Rodríguez-López; Myriam Rincón-Fontán; Alejandro López-Prieto; Xanel Vecino; José M Cruz
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

7.  Proof-of-Concept Organ-on-Chip Study: Topical Cinnamaldehyde Exposure of Reconstructed Human Skin with Integrated Neopapillae Cultured under Dynamic Flow.

Authors:  Irit Vahav; Maria Thon; Lenie J van den Broek; Sander W Spiekstra; Beren Atac; Gerd Lindner; Katharina Schimek; Uwe Marx; Susan Gibbs
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

Review 8.  In Vitro Strategies to Vascularize 3D Physiologically Relevant Models.

Authors:  Alessandra Dellaquila; Chau Le Bao; Didier Letourneur; Teresa Simon-Yarza
Journal:  Adv Sci (Weinh)       Date:  2021-08-05       Impact factor: 16.806

9.  Skin-on-a-chip models: General overview and future perspectives.

Authors:  I Risueño; L Valencia; J L Jorcano; D Velasco
Journal:  APL Bioeng       Date:  2021-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.